Thanks
Gastroenterologist
There are several promising new therapies currently under development but access to them is limited to clinical trials. Enrolement in clinical trials is according to strict criteria and usually means that you are ineligible if you have a stoma or are on total parenteral nutrition. The types of other medications you are on is also strictly limited and differs for the different agents being trialled.
The types of new therapies being trialled include drugs that impair the ability of white blood cells that cause the inflammation in Crohn's disease (and ulcerative colitis) from getting to the bowel to cause damage. There are IBD centres in most capital cities with access to these agents.
There are also new immune suppressive drugs that inhibits the signals in the white blood cells that cause IBD. One is a tablet which has been promising in rheumatoid arthritis and trials will start in Australia in the next few months.
Another injectible antibody drug will also be assessed in Australia and may particularly be an option for patients who have not responded to anti-TNF therapies (infliximab (Remicade)and adalimumab (Humira))
Another possible option is an Australian based stem cell infusion trial.
Crohn's and Colitis Australia (www.crohnsandcolitis.com.au) often have details on where trials are running or you doctor can contact one of the IBD specialists through AIBDA (Australian IBD Association) to try to find a local option (http://www.gesa.org.au/about.asp?cid=4&id=11).
Another suggestion for symptomatic help with a short gut with diarrhoea is to look at using St. Mark's solution to avoid dehydration and to decrease diarrhoea. (http://www.nwlh.nhs.uk/services/Resources/73_Understanding_IF.pdf)
You must be a HealthShare member to report this post. to your account or now (it's free).